# Specific Use-result Surveillance of Spiriva Respimat in Asthmatics

> **NCT02489981** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 359 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Spiriva

## Key facts

- **NCT ID:** NCT02489981
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-01
- **Primary completion:** 2017-08-01
- **Final completion:** 2017-09-28
- **Target enrollment:** 359 (ACTUAL)
- **Last updated:** 2019-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02489981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02489981, "Specific Use-result Surveillance of Spiriva Respimat in Asthmatics". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02489981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*